Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting matriptase expressing tumor cells with chemotherapeutic agents conjugated to matriptase antibodies

Targeting matriptase expressing tumor cells with chemotherapeutic agents conjugated to matriptase antibodies

US Patent 9682094 · Granted Jun 20, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase2023
Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase2023
Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase2023
Use of multi-frequency impedance cytometry in conjunction with machine learning 2023
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2019
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2019
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2019
Markers for abnormal cells2019
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2017
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2017
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2017
Specific delivery of toxins conjugated with antibodies to activate matripase2017